Author: Kosaka, Makoto; Yamazaki, Yoshitaka; Maruno, Takashi; Sakaguchi, Koji; Sawaki, Shoji
Title: Corticosteroids as adjunctive therapy in the treatment of coronavirus disease 2019: a report of two cases and literature review Cord-id: dmk7bsdi Document date: 2020_9_9
ID: dmk7bsdi
Snippet: The effect of systemic corticosteroids on clinical outcomes in patients with coronavirus disease 2019 (COVID-19) remains controversial. While the use of corticosteroids raises concerns regarding delayed viral clearance, secondary infections, and long-term complications that can lead to increased mortality, corticosteroids have the potential to reduce mortality if used appropriately. Herein, we report good outcomes in two patients with COVID-19 who received systemic corticosteroids as adjunctive
Document: The effect of systemic corticosteroids on clinical outcomes in patients with coronavirus disease 2019 (COVID-19) remains controversial. While the use of corticosteroids raises concerns regarding delayed viral clearance, secondary infections, and long-term complications that can lead to increased mortality, corticosteroids have the potential to reduce mortality if used appropriately. Herein, we report good outcomes in two patients with COVID-19 who received systemic corticosteroids as adjunctive therapy. An 83-year-old man with hypertension and smoking history and a 62-year-old man with a drinking habit were transferred to our hospital with a diagnosis of COVID-19. The patients developed general malaise and loss of appetite with persistent high fever. Despite the prescription of antiviral drugs, their hypoxemia progressed rapidly. However, after the introduction of systemic corticosteroids, their symptoms improved as the fever decreased, and their hypoxemia gradually improved. These results suggest that some patients with COVID-19 may benefit from the appropriate use of systemic corticosteroids as adjunctive therapy.
Search related documents:
Co phrase search for related documents- abnormal finding and acute respiratory infection: 1, 2, 3
- abnormal finding and lopinavir ritonavir: 1
- acute ards respiratory distress syndrome and adjunctive therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute ards respiratory distress syndrome and admission clinical course: 1, 2, 3, 4
- acute ards respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards respiratory distress syndrome and loss fatigue: 1
- acute ards respiratory distress syndrome and low dose corticosteroid: 1, 2, 3, 4
- acute ards respiratory distress syndrome and low middle: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute ards respiratory distress syndrome and lung field: 1, 2, 3
- acute respiratory infection and adjunctive therapy: 1, 2, 3, 4, 5
- acute respiratory infection and admission clinical course: 1, 2, 3
- acute respiratory infection and admission perform: 1
- acute respiratory infection and long term complication: 1, 2, 3
- acute respiratory infection and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory infection and loss fatigue: 1, 2, 3, 4, 5
- acute respiratory infection and loss fatigue fever: 1, 2
- acute respiratory infection and low middle: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- acute respiratory infection and lung field: 1, 2, 3
- adjunctive therapy and lopinavir ritonavir: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date